This company has been marked as potentially delisted and may not be actively trading. Xenetic Biosciences (XBIOW) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock XBIOW Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Xenetic Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 14, 2025 | gurufocus.comXenetic Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business ...May 14, 2025 | gurufocus.comXenetic: PeriNess in XBIO-015 study to treat osteosarcoma and Ewing sarcomaMarch 27, 2025 | markets.businessinsider.comXenetic: PeriNess in XBIO-015 study to treat osteosarcoma and Ewing sarcomaMarch 27, 2025 | markets.businessinsider.comXenetic partner PeriNess enters clinical study agreement for XBIO-015March 27, 2025 | markets.businessinsider.comXenetic partner PeriNess enters clinical study agreement for XBIO-015March 27, 2025 | markets.businessinsider.comH.C. Wainwright Remains a Hold on Xenetic Biosciences (XBIO)March 21, 2025 | markets.businessinsider.comXenetic presents preclinical data on DNase I with CAR T cells in murine modelMarch 13, 2025 | markets.businessinsider.comXenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology PlatformDecember 16, 2024 | investing.comAnalysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Context Therapeutics (CNTX) and Xenetic Biosciences (XBIO)December 5, 2024 | markets.businessinsider.comXenetic presents preclinical data on DNase platform technologyNovember 13, 2024 | markets.businessinsider.comXBIO Stock Earnings: Xenetic Biosciences Meets EPS, Beats Revenue for Q2 2024August 13, 2024 | investorplace.comXenetic Biosciences, Inc. (XBIO)August 10, 2024 | uk.finance.yahoo.comXenetic Biosciences, Inc. Announces Executive Leadership TransitionMay 22, 2024 | finance.yahoo.comXenetic Biosciences First Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagMay 12, 2024 | finance.yahoo.comXenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 10, 2024 | finance.yahoo.comXBIO Stock Earnings: Xenetic Biosciences Beats EPS, Misses Revenue for Q1 2024May 10, 2024 | investorplace.comXBIO Stock Earnings: Xenetic Biosciences Beats EPS, Misses Revenue for Q4 2023March 22, 2024 | msn.comXenetic Biosciences, Inc. Reports Full Year 2023 Financial ResultsMarch 22, 2024 | finance.yahoo.comXenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology PlatformJanuary 17, 2024 | finance.yahoo.comXenetic Biosciences reports Q3 resultsNovember 10, 2023 | msn.comXenetic Biosciences, Inc. Reports Third Quarter 2023 Financial ResultsNovember 10, 2023 | finance.yahoo.comXENX Historical DataSeptember 27, 2023 | investing.comXenetic Biosciences, Inc. (XBIOW)September 1, 2023 | finance.yahoo.comXenetic Biosciences (XBIO) Reports Q2 Loss, Tops Revenue EstimatesAugust 11, 2023 | msn.comXenetic Biosciences Shares Down 15% After Presentation, Tuesday IncreaseJuly 12, 2023 | marketwatch.comXenetic Biosciences, Inc. to Participate in the Virtual Investor Summer Spotlight SeriesJuly 5, 2023 | finance.yahoo.comXBIOW - Xenetic Biosciences, Inc.June 12, 2023 | ca.finance.yahoo.com Get Xenetic Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIOW and its competitors with MarketBeat's FREE daily newsletter. Email Address XBIOW Media Mentions By Week XBIOW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XBIOW News Sentiment▼0.000.71▲Average Medical News Sentiment XBIOW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XBIOW Articles This Week▼00▲XBIOW Articles Average Week Get Xenetic Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIOW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BCTXW News ENGNW News FBIOP News GOVXW News LEXXW News NTHI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XBIOW) was last updated on 6/6/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredHow to target 627% gains from Trump’s tweetsPresident Trump is shaking up the market with his tweets and Truth Social posts... But while this chaos has...Monument Traders Alliance | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredTrump plotting new lockdown?It's listed inside the White House's own documents: Federal Register notice 90 FR 4544 to be exact. And wh...Porter & Company | SponsoredWhy hasn't Elon tweeted about this?Behind the scenes, there's an entirely different Tesla story brewing… . It's about a quiet stream of income...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenetic Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenetic Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XBIOW Stock Free XBIOW Stock Alerts